20^th European Gastroenterology and Therapeutics Congress

GI Oncology: Colorectal and Pancreatic Cancers

Gastrointestinal oncology remains a key area of focus due to the high global burden of colorectal and pancreatic cancers. This session delves into the latest advances in early detection, diagnostics, treatment, and personalized medicine for GI malignancies. Colorectal cancer, often preventable through routine screening, benefits from innovations in non-invasive diagnostics like fecal DNA testing, liquid biopsy, and AI-enhanced colonoscopy. Pancreatic cancer, known for its late diagnosis and poor prognosis, is being tackled through biomarker discovery, targeted therapies, and immunotherapies. Experts will explore precision oncology approaches, molecular profiling, and the role of the tumor microenvironment in therapy resistance. This track also highlights the integration of minimally invasive surgery, neoadjuvant therapies, and patient-specific treatment planning. Emphasis will be placed on improving survival rates, enhancing quality of life, and addressing disparities in access to care. The session serves as a comprehensive update for clinicians, researchers, and policymakers tackling the evolving challenges in GI oncology.